REQUEST FOR PROPOSAL No. 03/2023-ABM – Phase II, Proof-of-Concept, clinical trial

The order is carried out in connection with the preparation of an application for co-financing as part of the competition: Development of targeted or personalised medicine based on nucleic acid and small molecule compounds-based medicinal products _ABM/2022/6, financed by the Medical Research Agency and in line with Call for proposals Regulation of the competition.

We hereby look for a Contractor ready to perform the Project: Preparation and comprehensive execution of the phase II, Proof-of-Concept, clinical trial in order to assess efficacy, pharmacokinetics, pharmacodynamics and safety of chitinase inhibitor OATD-01 in patients with active pulmonary sarcoidosis.

Please find attached the following documents:


03_2023_Appendix 1_CDA_PL_ENG_2022_osoba_prawna


On February 7, 2023, the Ordering Party updated the Appendix 7. The changes are marked in red and appropriately crossed out.


The Ordering Party provides answers to questions send by 09/02/2023 12:00 PM (CET).
03_2023_Questions to the Request for Proposal